Next Generation Sequencing (NGS) Informatics Market - Global Industry Size, Share, Trends, Competition, Opportunity, and Forecast, Segmented By Products & Services (Storage and Computing Tools, Commercial Data Analysis, Data Interpretation, and Reporting Tools, Next Generation Sequencing (NGS) Laboratory Information Management Systems (LIMS), By Application (Drug Discovery, Genetic Screening, Disease Diagnosis, and Others), By End User (Hospitals and Diagnostic Centers, Pharmaceutical and Biotechnology Companies, Academic and Research Institutions), By Region & Competition, 2020-2030F
Market Overview
The Global Next Generation Sequencing (NGS) Informatics Market was valued at USD 5.48 billion in 2024 and is projected to reach USD 18.74 billion by 2030, growing at a CAGR of 22.74%. The market is witnessing substantial growth due to the increasing incidence of cancer and expanding clinical applications of NGS. In 2020, the Global Cancer Observatory recorded over 19 million new cancer cases, with breast, lung, colorectal, prostate, and stomach cancers being the most common. Contributing to market expansion are the rising number of DNA sequencing samples, declining sequencing costs, government-backed genomic initiatives, and growing adoption of NGS over traditional microarray technologies. As sequencing becomes more affordable and integral to disease diagnosis and treatment, the demand for robust informatics platforms capable of managing, analyzing, and interpreting large-scale genomic data continues to grow.
Key Market Drivers
Rising Adoption of Precision Medicine and Genomic-Based Diagnostics
The widespread integration of precision medicine and genomic diagnostics into clinical workflows is a key driver of the NGS informatics market. By enabling the analysis of entire genetic profiles, NGS facilitates identification of disease-causing mutations and supports individualized treatment strategies. Government-led initiatives such as the NIH’s “All of Us Research Program” reflect this trend, collecting genetic data from over one million participants—over 600,000 of whom had enrolled by 2023. This surge in data fuels the demand for informatics platforms that can store, process, and interpret high-throughput sequencing information. Additionally, broader insurance coverage for genomic testing in countries like the United States is encouraging greater adoption of NGS technologies in hospitals and clinical labs. According to CMS, spending on NGS-based tests has significantly increased, underlining the growing clinical importance of these tools. As a result, demand for scalable NGS informatics systems that can automate variant analysis and support clinical decisions using AI and ML is accelerating across healthcare systems.
Key Market Trends
Integration of Artificial Intelligence and Machine Learning in NGS Informatics
The integration of AI and ML into NGS informatics is revolutionizing genomic data analysis by enabling rapid, accurate, and efficient interpretation of complex datasets. These technologies are embedded into pipelines for variant calling, annotation, and clinical reporting, helping to identify structural rearrangements and polygenic risk scores. Tools like DeepVariant and AlphaFold have improved the interpretation of genomic data in oncology and rare disease diagnostics. Government backing, such as the U.S. National Artificial Intelligence Initiative and the EU’s Horizon Europe program, underscores global efforts to integrate AI in biomedical research. AI models also enhance the utility of genomic data when integrated with electronic health records, enabling personalized, evidence-based treatment recommendations. As these models become increasingly sophisticated and validated, they are expected to become central to commercial NGS informatics solutions, supporting the broader implementation of precision medicine.
Key Market Players
Report Scope:
In this report, the Global Next Generation Sequencing (NGS) Informatics Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Competitive Landscape
Company Profiles: Detailed analysis of the major companies presents in the Global Next Generation Sequencing (NGS) Informatics Market.
Available Customizations:
Global Next Generation Sequencing (NGS) Informatics Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
The Global Next Generation Sequencing (NGS) Informatics Market was valued at USD 5.48 billion in 2024 and is projected to reach USD 18.74 billion by 2030, growing at a CAGR of 22.74%. The market is witnessing substantial growth due to the increasing incidence of cancer and expanding clinical applications of NGS. In 2020, the Global Cancer Observatory recorded over 19 million new cancer cases, with breast, lung, colorectal, prostate, and stomach cancers being the most common. Contributing to market expansion are the rising number of DNA sequencing samples, declining sequencing costs, government-backed genomic initiatives, and growing adoption of NGS over traditional microarray technologies. As sequencing becomes more affordable and integral to disease diagnosis and treatment, the demand for robust informatics platforms capable of managing, analyzing, and interpreting large-scale genomic data continues to grow.
Key Market Drivers
Rising Adoption of Precision Medicine and Genomic-Based Diagnostics
The widespread integration of precision medicine and genomic diagnostics into clinical workflows is a key driver of the NGS informatics market. By enabling the analysis of entire genetic profiles, NGS facilitates identification of disease-causing mutations and supports individualized treatment strategies. Government-led initiatives such as the NIH’s “All of Us Research Program” reflect this trend, collecting genetic data from over one million participants—over 600,000 of whom had enrolled by 2023. This surge in data fuels the demand for informatics platforms that can store, process, and interpret high-throughput sequencing information. Additionally, broader insurance coverage for genomic testing in countries like the United States is encouraging greater adoption of NGS technologies in hospitals and clinical labs. According to CMS, spending on NGS-based tests has significantly increased, underlining the growing clinical importance of these tools. As a result, demand for scalable NGS informatics systems that can automate variant analysis and support clinical decisions using AI and ML is accelerating across healthcare systems.
Key Market Trends
Integration of Artificial Intelligence and Machine Learning in NGS Informatics
The integration of AI and ML into NGS informatics is revolutionizing genomic data analysis by enabling rapid, accurate, and efficient interpretation of complex datasets. These technologies are embedded into pipelines for variant calling, annotation, and clinical reporting, helping to identify structural rearrangements and polygenic risk scores. Tools like DeepVariant and AlphaFold have improved the interpretation of genomic data in oncology and rare disease diagnostics. Government backing, such as the U.S. National Artificial Intelligence Initiative and the EU’s Horizon Europe program, underscores global efforts to integrate AI in biomedical research. AI models also enhance the utility of genomic data when integrated with electronic health records, enabling personalized, evidence-based treatment recommendations. As these models become increasingly sophisticated and validated, they are expected to become central to commercial NGS informatics solutions, supporting the broader implementation of precision medicine.
Key Market Players
- Abbott Laboratories
- F. Hoffmann-La Roche Ltd.
- PerkinElmer, Inc.
- SOPHiA GENETICS SA
- Precigen, Inc.
- QIAGEN N.V.
- Illumina, Inc.
- Agilent Technologies, Inc.
- Eagle Genomics Limited
- BGI Genomics Co., Ltd.
Report Scope:
In this report, the Global Next Generation Sequencing (NGS) Informatics Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
- Next Generation Sequencing (NGS) Informatics Market, By Product & Services:
- Storage and Computing Tools
- Commercial Data Analysis
- Data Interpretation and Reporting Tools
- Next Generation Sequencing (NGS) Informatics Services
- Laboratory Information Management Systems (LIMS)
- Next Generation Sequencing (NGS) Informatics Market, By Application:
- Drug Discovery
- Genetic Screening
- Disease Diagnosis
- Others
- Next Generation Sequencing (NGS) Informatics Market, By End User:
- Hospitals and Diagnostic Centers
- Pharmaceutical and Biotechnology Companies
- Academic and Research Institutions
- Next Generation Sequencing (NGS) Informatics Market, By Region:
- North America
- United States
- Mexico
- Canada
- Europe
- France
- Germany
- United Kingdom
- Italy
- Spain
- Asia-Pacific
- China
- India
- South Korea
- Japan
- Australia
- South America
- Brazil
- Argentina
- Colombia
- Middle East and Africa
- South Africa
- Saudi Arabia
- UAE
Competitive Landscape
Company Profiles: Detailed analysis of the major companies presents in the Global Next Generation Sequencing (NGS) Informatics Market.
Available Customizations:
Global Next Generation Sequencing (NGS) Informatics Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
- Detailed analysis and profiling of additional market players (up to five).
1. PRODUCT OVERVIEW
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. RESEARCH METHODOLOGY
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. EXECUTIVE SUMMARY
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. VOICE OF CUSTOMER
5. GLOBAL NEXT GENERATION SEQUENCING (NGS) INFORMATICS MARKET OUTLOOK
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Products & Services (Storage and Computing Tools, Commercial Data Analysis, Data Interpretation, and Reporting Tools, Next Generation Sequencing (NGS) Informatics Services, Laboratory Information Management Systems (LIMS))
5.2.2. By Application (Drug Discovery, Genetic Screening, Disease Diagnosis, and Others)
5.2.3. By End User (Hospitals and Diagnostic Centers, Pharmaceutical and Biotechnology Companies, Academic and Research Institutions)
5.2.4. By Region (North America, Europe, Asia Pacific, South America, Middle East, and Africa)
5.2.5. By Company (2024)
5.3. Market Map
5.3.1. By Products & Services
5.3.2. By Application
5.3.3. By End User
5.3.4. By Region
6. NORTH AMERICA NEXT GENERATION SEQUENCING (NGS) INFORMATICS MARKET OUTLOOK
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Products & Services
6.2.2. By Application
6.2.3. By End User
6.2.4. By Country
6.3. North America: Country Analysis
6.3.1. United States Next Generation Sequencing (NGS) Informatics Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Products & Services
6.3.1.2.2. By Application
6.3.1.2.3. By End User
6.3.2. Canada Next Generation Sequencing (NGS) Informatics Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Products & Services
6.3.2.2.2. By Application
6.3.2.2.3. By End User
6.3.3. Mexico Next Generation Sequencing (NGS) Informatics Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Products & Services
6.3.3.2.2. By Application
6.3.3.2.3. By End User
7. EUROPE NEXT GENERATION SEQUENCING (NGS) INFORMATICS MARKET OUTLOOK
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Products & Services
7.2.2. By Application
7.2.3. By End User
7.2.4. By Country
7.3. Europe: Country Analysis
7.3.1. Germany Next Generation Sequencing (NGS) Informatics Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Products & Services
7.3.1.2.2. By Application
7.3.1.2.3. By End User
7.3.1.2.4. By Country
7.3.2. France Next Generation Sequencing (NGS) Informatics Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Products & Services
7.3.2.2.2. By Application
7.3.2.2.3. By End User
7.3.3. United Kingdom Next Generation Sequencing (NGS) Informatics Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Products & Services
7.3.3.2.2. By Application
7.3.3.2.3. By End User
7.3.4. Italy Next Generation Sequencing (NGS) Informatics Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Products & Services
7.3.4.2.2. By Application
7.3.4.2.3. By End User
7.3.5. Spain Next Generation Sequencing (NGS) Informatics Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Products & Services
7.3.5.2.2. By Application
7.3.5.2.3. By End User
8. ASIA-PACIFIC NEXT GENERATION SEQUENCING (NGS) INFORMATICS MARKET OUTLOOK
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Products & Services
8.2.2. By Application
8.2.3. By End User
8.2.4. By Country
8.3. Asia-Pacific: Country Analysis
8.3.1. China Next Generation Sequencing (NGS) Informatics Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Products & Services
8.3.1.2.2. By Application
8.3.1.2.3. By End User
8.3.2. Japan Next Generation Sequencing (NGS) Informatics Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Products & Services
8.3.2.2.2. By Application
8.3.2.2.3. By End User
8.3.3. India Next Generation Sequencing (NGS) Informatics Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Products & Services
8.3.3.2.2. By Application
8.3.3.2.3. By End User
8.3.4. South Korea Next Generation Sequencing (NGS) Informatics Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Products & Services
8.3.4.2.2. By Application
8.3.4.2.3. By End User
8.3.5. Australia Next Generation Sequencing (NGS) Informatics Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Products & Services
8.3.5.2.2. By Application
8.3.5.2.3. By End User
9. SOUTH AMERICA NEXT GENERATION SEQUENCING (NGS) INFORMATICS MARKET OUTLOOK
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Products & Services
9.2.2. By Application
9.2.3. By End User
9.2.4. By Country
9.3. South America: Country Analysis
9.3.1. Brazil Next Generation Sequencing (NGS) Informatics Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Products & Services
9.3.1.2.2. By Application
9.3.1.2.3. By End User
9.3.2. Argentina Next Generation Sequencing (NGS) Informatics Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Products & Services
9.3.2.2.2. By Application
9.3.2.2.3. By End User
9.3.3. Colombia Next Generation Sequencing (NGS) Informatics Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Products & Services
9.3.3.2.2. By Application
9.3.3.2.3. By End User
10. MIDDLE EAST AND AFRICA NEXT GENERATION SEQUENCING (NGS) INFORMATICS MARKET OUTLOOK
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Products & Services
10.2.2. By Application
10.2.3. By End User
10.2.4. By Country
10.3. MEA: Country Analysis
10.3.1. UAE Next Generation Sequencing (NGS) Informatics Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Products & Services
10.3.1.2.2. By Application
10.3.1.2.3. By End User
10.3.2. Saudi Arabia Next Generation Sequencing (NGS) Informatics Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Products & Services
10.3.2.2.2. By Application
10.3.2.2.3. By End User
10.3.3. South Africa Next Generation Sequencing (NGS) Informatics Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Products & Services
10.3.3.2.2. By Application
10.3.3.2.3. By End User
11. MARKET DYNAMICS
11.1. Drivers
11.2. Challenges
12. MARKET TRENDS & DEVELOPMENTS
12.1. Merger & Acquisition (If Any)
12.2. Product Launches (If Any)
12.3. Recent Developments
13. PORTERS FIVE FORCES ANALYSIS
13.1. Competition in the Industry
13.2. Potential of New Entrants
13.3. Power of Suppliers
13.4. Power of Customers
13.5. Threat of Substitute Products/Services
14. GLOBAL NEXT GENERATION SEQUENCING (NGS) INFORMATICS MARKET: SWOT ANALYSIS
15. COMPETITIVE LANDSCAPE
15.1. Abbott Laboratories
15.1.1. Business Overview
15.1.2. Company Snapshot
15.1.3. Products & Services
15.1.4. Financials (As Reported)
15.1.5. Recent Developments
15.1.6. Key Personnel Details
15.1.7. SWOT Analysis
15.2. F. Hoffmann-La Roche Ltd.
15.3. PerkinElmer, Inc.
15.4. SOPHiA GENETICS SA
15.5. Precigen, Inc.
15.6. QIAGEN N.V.
15.7. Illumina, Inc.
15.8. Agilent Technologies, Inc.
15.9. Eagle Genomics Limited
15.10. BGI Genomics Co., Ltd.
16. STRATEGIC RECOMMENDATIONS
17. ABOUT US & DISCLAIMER
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. RESEARCH METHODOLOGY
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. EXECUTIVE SUMMARY
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. VOICE OF CUSTOMER
5. GLOBAL NEXT GENERATION SEQUENCING (NGS) INFORMATICS MARKET OUTLOOK
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Products & Services (Storage and Computing Tools, Commercial Data Analysis, Data Interpretation, and Reporting Tools, Next Generation Sequencing (NGS) Informatics Services, Laboratory Information Management Systems (LIMS))
5.2.2. By Application (Drug Discovery, Genetic Screening, Disease Diagnosis, and Others)
5.2.3. By End User (Hospitals and Diagnostic Centers, Pharmaceutical and Biotechnology Companies, Academic and Research Institutions)
5.2.4. By Region (North America, Europe, Asia Pacific, South America, Middle East, and Africa)
5.2.5. By Company (2024)
5.3. Market Map
5.3.1. By Products & Services
5.3.2. By Application
5.3.3. By End User
5.3.4. By Region
6. NORTH AMERICA NEXT GENERATION SEQUENCING (NGS) INFORMATICS MARKET OUTLOOK
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Products & Services
6.2.2. By Application
6.2.3. By End User
6.2.4. By Country
6.3. North America: Country Analysis
6.3.1. United States Next Generation Sequencing (NGS) Informatics Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Products & Services
6.3.1.2.2. By Application
6.3.1.2.3. By End User
6.3.2. Canada Next Generation Sequencing (NGS) Informatics Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Products & Services
6.3.2.2.2. By Application
6.3.2.2.3. By End User
6.3.3. Mexico Next Generation Sequencing (NGS) Informatics Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Products & Services
6.3.3.2.2. By Application
6.3.3.2.3. By End User
7. EUROPE NEXT GENERATION SEQUENCING (NGS) INFORMATICS MARKET OUTLOOK
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Products & Services
7.2.2. By Application
7.2.3. By End User
7.2.4. By Country
7.3. Europe: Country Analysis
7.3.1. Germany Next Generation Sequencing (NGS) Informatics Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Products & Services
7.3.1.2.2. By Application
7.3.1.2.3. By End User
7.3.1.2.4. By Country
7.3.2. France Next Generation Sequencing (NGS) Informatics Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Products & Services
7.3.2.2.2. By Application
7.3.2.2.3. By End User
7.3.3. United Kingdom Next Generation Sequencing (NGS) Informatics Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Products & Services
7.3.3.2.2. By Application
7.3.3.2.3. By End User
7.3.4. Italy Next Generation Sequencing (NGS) Informatics Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Products & Services
7.3.4.2.2. By Application
7.3.4.2.3. By End User
7.3.5. Spain Next Generation Sequencing (NGS) Informatics Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Products & Services
7.3.5.2.2. By Application
7.3.5.2.3. By End User
8. ASIA-PACIFIC NEXT GENERATION SEQUENCING (NGS) INFORMATICS MARKET OUTLOOK
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Products & Services
8.2.2. By Application
8.2.3. By End User
8.2.4. By Country
8.3. Asia-Pacific: Country Analysis
8.3.1. China Next Generation Sequencing (NGS) Informatics Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Products & Services
8.3.1.2.2. By Application
8.3.1.2.3. By End User
8.3.2. Japan Next Generation Sequencing (NGS) Informatics Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Products & Services
8.3.2.2.2. By Application
8.3.2.2.3. By End User
8.3.3. India Next Generation Sequencing (NGS) Informatics Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Products & Services
8.3.3.2.2. By Application
8.3.3.2.3. By End User
8.3.4. South Korea Next Generation Sequencing (NGS) Informatics Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Products & Services
8.3.4.2.2. By Application
8.3.4.2.3. By End User
8.3.5. Australia Next Generation Sequencing (NGS) Informatics Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Products & Services
8.3.5.2.2. By Application
8.3.5.2.3. By End User
9. SOUTH AMERICA NEXT GENERATION SEQUENCING (NGS) INFORMATICS MARKET OUTLOOK
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Products & Services
9.2.2. By Application
9.2.3. By End User
9.2.4. By Country
9.3. South America: Country Analysis
9.3.1. Brazil Next Generation Sequencing (NGS) Informatics Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Products & Services
9.3.1.2.2. By Application
9.3.1.2.3. By End User
9.3.2. Argentina Next Generation Sequencing (NGS) Informatics Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Products & Services
9.3.2.2.2. By Application
9.3.2.2.3. By End User
9.3.3. Colombia Next Generation Sequencing (NGS) Informatics Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Products & Services
9.3.3.2.2. By Application
9.3.3.2.3. By End User
10. MIDDLE EAST AND AFRICA NEXT GENERATION SEQUENCING (NGS) INFORMATICS MARKET OUTLOOK
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Products & Services
10.2.2. By Application
10.2.3. By End User
10.2.4. By Country
10.3. MEA: Country Analysis
10.3.1. UAE Next Generation Sequencing (NGS) Informatics Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Products & Services
10.3.1.2.2. By Application
10.3.1.2.3. By End User
10.3.2. Saudi Arabia Next Generation Sequencing (NGS) Informatics Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Products & Services
10.3.2.2.2. By Application
10.3.2.2.3. By End User
10.3.3. South Africa Next Generation Sequencing (NGS) Informatics Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Products & Services
10.3.3.2.2. By Application
10.3.3.2.3. By End User
11. MARKET DYNAMICS
11.1. Drivers
11.2. Challenges
12. MARKET TRENDS & DEVELOPMENTS
12.1. Merger & Acquisition (If Any)
12.2. Product Launches (If Any)
12.3. Recent Developments
13. PORTERS FIVE FORCES ANALYSIS
13.1. Competition in the Industry
13.2. Potential of New Entrants
13.3. Power of Suppliers
13.4. Power of Customers
13.5. Threat of Substitute Products/Services
14. GLOBAL NEXT GENERATION SEQUENCING (NGS) INFORMATICS MARKET: SWOT ANALYSIS
15. COMPETITIVE LANDSCAPE
15.1. Abbott Laboratories
15.1.1. Business Overview
15.1.2. Company Snapshot
15.1.3. Products & Services
15.1.4. Financials (As Reported)
15.1.5. Recent Developments
15.1.6. Key Personnel Details
15.1.7. SWOT Analysis
15.2. F. Hoffmann-La Roche Ltd.
15.3. PerkinElmer, Inc.
15.4. SOPHiA GENETICS SA
15.5. Precigen, Inc.
15.6. QIAGEN N.V.
15.7. Illumina, Inc.
15.8. Agilent Technologies, Inc.
15.9. Eagle Genomics Limited
15.10. BGI Genomics Co., Ltd.
16. STRATEGIC RECOMMENDATIONS
17. ABOUT US & DISCLAIMER
